Avalo Therapeutics Inc (AVTX)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 123.11M
P/E Ratio
1.43
Revenue (TTM)
$ 441K
Volume
0
52W High
$ 16.00
52W Low
$ 3.39
Dividend Yield
0.00%
Beta
0.82
Technicals
50-Day MA
5.7627
200-Day MA
7.3175
52 Week High
16
52 Week Low
3.39
About AVTX
Avalo Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States.
Employees
23
Headquarters
Rockville, MD
CEO
Dr. Garry A. Neil M.D.